908 Devices Inc. (MASS) Revenue History
908 Devices Inc. (MASS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $42.21M |
| 2022-12-31 | $46.85M |
| 2023-12-31 | $50.23M |
| 2024-12-31 | $47.75M |
| 2025-12-31 | $56.20M |
How MASS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NKTR | Nektar Therapeutics | $55.23M |
| AGIO | Agios Pharmaceuticals Inc. | $54.03M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
These are five companies in the same sector as MASS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get 908 Devices Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("MASS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MASS | $10.24 | +1.59% | 0.65M |
| 3 | ||||
| 4 | ||||
| 5 |